| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...744267C |
| P356 | DOI | 10.1371/JOURNAL.PONE.0044267 |
| P953 | full work available online at | https://europepmc.org/articles/PMC3436881 |
| https://europepmc.org/articles/PMC3436881?pdf=render | ||
| https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0044267&type=printable | ||
| P932 | PMC publication ID | 3436881 |
| P698 | PubMed publication ID | 22970192 |
| P5875 | ResearchGate publication ID | 230834574 |
| P50 | author | Sherri L Christian | Q85344733 |
| P2093 | author name string | Dong Zu | |
| Kensuke Hirasawa | |||
| Maria Licursi | |||
| Theerawat Pongnopparat | |||
| Yumiko Komatsu | |||
| Dianne A. Codner | |||
| P2860 | cites work | Bioconductor: open software development for computational biology and bioinformatics | Q21194861 |
| Interaction of tumor cells with the microenvironment | Q21245506 | ||
| Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus | Q24292060 | ||
| The human interferon alpha/beta receptor: characterization and molecular cloning | Q24313421 | ||
| The Interferon Stimulated Gene 54 Promotes Apoptosis | Q24321910 | ||
| The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus | Q24533256 | ||
| A diverse range of gene products are effectors of the type I interferon antiviral response | Q24626018 | ||
| Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex | Q24647642 | ||
| The MAP2/Tau family of microtubule-associated proteins | Q24805413 | ||
| High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). | Q24815153 | ||
| The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses | Q27860685 | ||
| A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 | ||
| Exploration, normalization, and summaries of high density oligonucleotide array probe level data | Q27861098 | ||
| Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon snd silencing by hypermethylation | Q28115670 | ||
| Organization of the genes encoding the human proteasome activators PA28alpha and beta | Q28141347 | ||
| The cluster of BTN genes in the extended major histocompatibility complex | Q28199806 | ||
| Targeting RAS signalling pathways in cancer therapy | Q28201363 | ||
| Chromatin-remodelling factor BRG1 selectively activates a subset of interferon-alpha-inducible genes | Q28203242 | ||
| 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members | Q28513232 | ||
| Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1. | Q40788613 | ||
| Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis | Q40906922 | ||
| Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression. | Q41071715 | ||
| Activated Ras/MEK inhibits the antiviral response of alpha interferon by reducing STAT2 levels | Q41359622 | ||
| Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway | Q42425053 | ||
| Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain | Q42817953 | ||
| Oncogenic Ras promotes reovirus spread by suppressing IFN-beta production through negative regulation of RIG-I signaling | Q42826443 | ||
| Oncogenic RAS alters the global and gene-specific histone modification pattern during epithelial-mesenchymal transition in colorectal carcinoma cells | Q43181728 | ||
| A genetically engineered influenza A virus with ras-dependent oncolytic properties | Q45734706 | ||
| PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. | Q46006991 | ||
| Use of within-array replicate spots for assessing differential expression in microarray experiments | Q48502901 | ||
| Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro | Q57055052 | ||
| SnapShot: Ras Signaling | Q57903531 | ||
| Ras-dependent oncolysis with an adenovirus VAI mutant | Q64377417 | ||
| Defective Antigen Processing in GILT-Free Mice | Q28586564 | ||
| Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures | Q29615028 | ||
| MAP kinase signalling pathways in cancer | Q29615542 | ||
| Hyperactive Ras in developmental disorders and cancer | Q29616397 | ||
| Genesis: cluster analysis of microarray data | Q29619630 | ||
| Cytokines and JAK-STAT signaling | Q33783480 | ||
| Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus | Q33908950 | ||
| Functional classification of interferon-stimulated genes identified using microarrays | Q33951179 | ||
| A framework for oligonucleotide microarray preprocessing. | Q34149103 | ||
| When the SWI/SNF complex remodels...the cell cycle | Q34290272 | ||
| Development of anticancer drugs targeting the MAP kinase pathway | Q34293560 | ||
| MAPK signal-integrating kinase controls cap-independent translation and cell type-specific cytotoxicity of an oncolytic poliovirus | Q34343725 | ||
| An adenovirus mutant that replicates selectively in p53-deficient human tumor cells | Q34399844 | ||
| The role of interferon in cancer therapy: a current perspective | Q34407548 | ||
| Reovirus therapy of tumors with activated Ras pathway | Q34479740 | ||
| Antiretroviral potential of human tripartite motif-5 and related proteins | Q34545890 | ||
| Identification of Japanese encephalitis virus-inducible genes in mouse brain and characterization of GARG39/IFIT2 as a microtubule-associated protein. | Q34572753 | ||
| APOBEC3 inhibits mouse mammary tumour virus replication in vivo. | Q34607167 | ||
| Cyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells. | Q35023710 | ||
| Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. | Q35358944 | ||
| Inhibitor of κB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection | Q35639771 | ||
| Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery | Q36162904 | ||
| Viral interactions with the cytoskeleton: a hitchhiker's guide to the cell | Q36392210 | ||
| A superhighway to virus infection | Q36404651 | ||
| Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions. | Q36636878 | ||
| Interferon therapy in cancer: from imaginon to interferon. | Q38164644 | ||
| NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity. | Q38315256 | ||
| The PKR kinase promoter binds both Sp1 and Sp3, but only Sp3 functions as part of the interferon-inducible complex with ISGF-3 proteins | Q38350820 | ||
| Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells | Q38362539 | ||
| Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virus | Q39747959 | ||
| Effect of p38 Mitogen-Activated Protein Kinase on the Replication of Encephalomyocarditis Virus | Q39748972 | ||
| An elaborate pathway required for Ras-mediated epigenetic silencing | Q40062561 | ||
| Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-alpha resistance | Q40119012 | ||
| SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells | Q40131207 | ||
| The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells | Q40132472 | ||
| Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release | Q40141506 | ||
| A distal regulatory region is required for constitutive and IFN-beta-induced expression of murine TLR9 gene. | Q40348773 | ||
| Chronic myeloid leukemia cells resistant to interferon-alpha lack STAT1 expression | Q40741810 | ||
| Oncolytic reovirus against ovarian and colon cancer. | Q40742634 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e44267 | |
| P577 | publication date | 2012-09-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Suppression of IFN-induced transcription underlies IFN defects generated by activated Ras/MEK in human cancer cells | |
| Suppression of IFN-Induced Transcription Underlies IFN Defects Generated by Activated Ras/MEK in Human Cancer Cells | |||
| P478 | volume | 7 |
| Q37612580 | A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection |
| Q64094642 | Baicalein Suppresses Stem Cell-Like Characteristics in Radio- and Chemoresistant MDA-MB-231 Human Breast Cancer Cells through Up-Regulation of IFIT2 |
| Q38955561 | Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model. |
| Q59352746 | Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses |
| Q40411967 | Global gene analysis identifying genes commonly regulated by the Ras/Raf/MEK and type I IFN pathways |
| Q40067130 | H-Ras Exerts Opposing Effects on Type I Interferon Responses Depending on Its Activation Status |
| Q35842588 | High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells |
| Q36100040 | IRF1 Downregulation by Ras/MEK Is Independent of Translational Control of IRF1 mRNA. |
| Q90050672 | MEK1/2 Inhibitors Unlock the Constrained Interferon Response in Macrophages Through IRF1 Signaling |
| Q26739777 | Oncogenes: The Passport for Viral Oncolysis Through PKR Inhibition |
| Q38944907 | Oncogenic Ras inhibits IRF1 to promote viral oncolysis |
| Q41699675 | Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer |
| Q33743847 | Permissiveness of human cancer cells to oncolytic bovine herpesvirus 1 is mediated in part by KRAS activity |
| Q38432883 | RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective. |
| Q36188447 | Ras transformation results in cleavage of reticulon protein Nogo-B that is associated with impairment of IFN response |
| Q28079490 | The Importance of Physiologically Relevant Cell Lines for Studying Virus-Host Interactions |
| Q40444191 | The Interaction Between Human Papillomaviruses and the Stromal Microenvironment |
| Q54121472 | The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells. |
| Q51846287 | Tumor Restrictions to Oncolytic Virus |
| Q57469278 | Unscheduled HDAC4 repressive activity in human fibroblasts triggers TP53-dependent senescence and favours cell transformation |
| Q38940626 | Up-regulation of GBP2 is Associated with Neuronal Apoptosis in Rat Brain Cortex Following Traumatic Brain Injury |
Search more.